Kendal born hospital exec suspended

THE chief executive of a leading cancer hospital - who was born and bred in Kendal - has been suspended.

Caroline Shaw won an award for 'exceptional leadership' at The Christie in Manchester, a pioneering cancer research centre.

Lord Keith Bradley, Chairman of The Christie NHS Foundation Trust said: “Caroline Shaw, Chief Executive of the Trust, was suspended yesterday while investigations are underway as part of a disciplinary process.

"This is neutral action and follows the Trust’s normal processes.

"We have put arrangements in place to ensure both the Trust’s and charity’s activities continue to be delivered to the very highest standards, and I would like to reassure patients, families and carers that this situation in no way affects or compromises patient care.

"Patients are, and always will be our priority, and we remain committed to providing the very best standards of care and treatment in a world class cancer centre.”

Mrs Shaw, who took up the position in 2005, was given an CBE in the last New Year's honours list.

She said: "I am honoured to be the Chief Executive Officer of The Christie NHS Foundation Trust and to have held this role since 2005.

“Together with a hugely supportive board of directors, world class clinicians and a passionate management team, we have led the trust from running a deficit of £3.4 million and being unable to meet national cancers targets, to consistently highly performing in the delivery of service outcomes and patient experience. Further, we recorded a surplus of £8.6 million in the last financial year. I am extremely proud of our current national and international standing.

“I was informed yesterday [19th December] that I have been suspended pending an inquiry into an internal allegation, as per our rigorous processes. I completely understand that when any allegation is made this process must be followed and I welcome a full investigation into the matter. I will be giving my total co-operation, confident of a swift and positive conclusion.

"With respect to the process, I will not be commenting further until the inquiry is concluded and I look forward to soon resuming our journey to provide the very best in cancer care to the people that matter most."



Comments are closed on this article.


About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree